Algert Global LLC Mirum Pharmaceuticals, Inc. Transaction History

Algert Global LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$23.51 - $30.09 $609,849 - $780,534	25,940 New	25,940 $671,000
Q3 2022 Nov 15, 2022	SELL	$19.98 - $29.44 $67,232 - $99,065	-3,365 Reduced 12.86%	22,805 $479,000
Q2 2022 Aug 15, 2022	BUY	$18.42 - $27.5 $482,051 - $719,675	26,170 New	26,170 $509,000

190

54M

177K

167K

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.61B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.